• Home
  • MyECTS
  • Become a member
  • Contact us

Ectsoc

Ecstoc.org

MENUMENU
  • About
    • Mission & Vision
    • Governance & Transparency
    • Board of Directors
    • Annual General Meeting
    • Committees and Action Groups
      • Executive Committee
      • Communications Committee
      • Community Engagement Committee
      • ECTS Academy
      • Education Committee
      • Clinical Science Committee
      • Research Committee
      • Scientific Programme Committee 2025
    • ECTS Team
    • Membership
      • Individual Membership
      • Corporate Supporters
      • Join us
      • Affiliated Societies
  • ECTS 2025
  • Events
    • Upcoming Congresses
    • Past Congress
    • ECTS Academy Charity Event
    • ICCBH
    • Events
  • Grants & Awards
  • Education
    • PhD Training Course
    • Clinical Training Course in Metabolic Bone Diseases
    • Rare Bone Diseases Webinars
    • Education Resource Center
    • Bone Muscle & Beyond Webinars
    • ECTS-Mellanby Training Course
    • Calendar ECTS Educational Events
  • ECTS Academy
    • About the ECTS Academy
    • ECTS Academy – Members
    • Call for Applications - Basic Scientists
    • Call for Applications - Clinicians
    • ECTS Academy Activities
      • NI Conference Program
      • ECTS Academy Webinar Series
      • ECTS Academy Mentoring Options
      • ECTS Academy Charity Run
    • Visit the ECTS Academy website
  • News
    • ECTS Newsletter
    • News
    • Press Release
    • Image Library
    • Video Library
    • Job Advertisements
You are here: Home / Boards / Andre van Wijen

May 13 2019

Andre van Wijen

Dr. van Wijnen received BSc (1983) and MSc (1987) degrees from the University of Utrecht, Netherlands while also affiliated with the University of Florida (1984-1987). He received his PhD from UMass Medical School (Worcester, MA) in 1991, and ascended the academic faculty ranks (Assistant Professor, Associate Professor and Professor). In 2012, he established a new research group at Mayo Clinic focusing on orthopedic tissue regeneration, musculoskeletal tumors and translational applications. Currently, he has an H-factor of 75 and has authored >500 PubMed papers that have been collectively cited >20,000 times .

The van Wijnen group focuses on projects that examine biological and mechanistic questions fundamental to regulation and deregulation of bone cell growth and differentiation using state-of-the-art approaches including genomics, proteomics, mouse genetics and microscopy to address gene regulation, cell signaling, microRNAs and epigenetics. The group has broad interests on biological mechanisms and patient-oriented research related to regenerative medicine, musculoskeletal development (bone, cartilage, ligament & tendon), as well as pluripotent embryonic and multipotent adult stem cells.

Copyright 2016 ECTS - Disclaimer - Cookies Policy - Privacy Policy - Privacy Centre - Terms of use - Contact us